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I. Methods 
 
A. Determination of Trans Chromosomal Configuration of MUTYH Gene Variants 
Germline DNA was amplified using the polymerase chain reaction (PCR) to generate a 
935 base pair amplicon that includes the open reading frame positions c.918C>G 
(p.C306W) and c.1187G>A (p.G396D). The PCR reaction used the forward primer 5ʹ-
CCA GGA GAT TTC AAC CAA GC-3ʹ and the reverse primer 5ʹ -AAG GGT CAA 
GGG GTT CAA AT-3ʹ. The c.1187G>A mutation creates a unique BglII restriction 
endonuclease site which allowed generation of a 719 base pair fragment from the parent 
935 base pair amplicon. The shorter 719 base pair fragment was resolved using agarose 
gel electrophoresis, purified and its DNA sequence determined (University of Michigan 
(U-M) Sequencing Core) to establish the identity of the c.918 position. 
B. Identification of APC gene G:C  T:A Transversions 
Tumor DNA was extracted from a formalin-fixed, paraffin-embedded colonic adenoma 
originating from the proband using the RecoverAll Total Nucleic Acid isolation kit 
(Ambion).  A portion of the mutation cluster region of the APC gene1 was amplified 
using PCR with the forward primer 5ʹ-TGC CAC AGA TAT TCC TTC ATC A-3ʹ and 
the reverse primer 5ʹ-CAT GGT TTG TCC AGG GCT AT-3ʹ. The PCR product was 
subsequently sequenced (U-M Sequencing Core). 
 
C. Cloning of wild type and Mutant MUTYH expression plasmids 
A plasmid containing the open reading frame for the beta3 isoform of MUTYH 
(NM_001048174.1) was obtained from OriGene (Catalog #: RC201376-OR, Rockville, 
MD.) and used as a template for the cloning of derivative constructs.  Mutant MUTYH 
construct synthesis was accomplished using PCR-based site-directed mutagenesis of wild 
type MUTYH. The wild type and mutants were then cloned as maltose binding protein 
(MBP) fusions into pMCSG192 between the KpnI and XbaI restriction sites to increase 
protein solubility3. The plasmids were further modified by removing the first fourteen 
codons encoding the mitochondrial recognition sequence, which alleviated heterologous 
protein toxicity. Furthermore, to decrease the capture of truncated heterologous protein, 
the N-terminus His6 tag located between the MBP sequence and the TEV cleavage site 
was removed and a C-terminus His10 tag was attached with a flexible (SG)7 linker to 
increase solvent exposure.  
 
 
 
 
 
 
 
 
Page | 3  
 
D. Preparation of Protein 
Heterologous MUTYH proteins in Escherichia coli strain BL21(DE3) were initially 
purified in accordance with previously published protocols using nickel affinity 
chromatography with 1 mM DTT4. To improve yields and purity, the expression plasmids 
were transformed into the E. coli expression strain for toxic proteins, BL-AI (Invitrogen) 
also harboring the rare codon plasmid pRARE2-CDF5. One liter of fresh Terrific Broth 
modified with 4% glycerol and 50 µg/mL of antibiotics (ampicillin and streptomycin) in 
a three L baffled flask was inoculated with 25 mL of overnight cultures in the same 
medium. Cultures were grown at 37 ºC in a horizontal shaker at 175 rpm until the OD600 
reached approximately 2.5. The temperature was adjusted to 15 ºC, and after 90 minutes, 
0.25 mM IPTG and 0.2% arabinose were added. After 12-16 hours, cells were harvested 
by centrifugation, flash frozen in liquid nitrogen, and stored at -80 °C until processing. 
Cell pellets were thawed in an ice bath and re-suspended in 80 mL of ice cold 10% 
glycerol before the addition of 53 mg/mL of CelLytic Express (Sigma), one tablet of 
Protease Inhibitor Cocktail (Sigma) and 20 mM imidazole. The samples were clarified on 
a nutator for 30 minutes at 4ºC before the addition of 20 mM of β-mercaptoethanol. The 
crude cell lysate was passed through a 0.45 µm filter in preparation for nickel affinity 
chromatography. His-tagged proteins were loaded onto a 5 mL HisTrap HP column (GE 
Healthcare) at 2 mL/min using an AKTA Explorer FPLC instrument (GE Healthcare) at 4 
ºC. The columns were first washed with 20 column volumes of 93% Buffer A (20 mM 
Tris-HCl, pH 7.4, 1 M NaCl, 20 mM β-mercaptoethanol, 10% glycerol) and 7% Buffer B 
(20 mM Tris-HCl, pH 7.4, 100 mM NaCl, 500 mM imidazole, 10% glycerol) and the 
proteins were eluted using a 7-100% Buffer B gradient over 10 column volumes. 
Fractions containing MBP-MUTYH protein (as determined by SDS-PAGE), were 
pooled. Typical yields of purified protein for MBP-MUTYH wild type, Y179C and 
G396D were between 10-20 mg from one liter cultures and 0.5-1.5 mg of soluble protein 
was obtained for MUTYH p.C306W. Monomeric protein was obtained by size exclusion 
chromatography using a Superdex 200 10/300 GL column (GE Healthcare) in Buffer C 
(20 mM Tris-HCl, 100 mM NaCl, 1 mM DTT, 10% glycerol). Fractions eluting near the 
expected molecular weight (104 kD) were collected, partitioned into aliquots, flash 
frozen in liquid nitrogen and stored at -80 ºC until further use.  
 
E. DNA Substrates for Glycosylase and Binding Assays 
All oligonucleotides (Integrated DNA Technologies, Coralville, Iowa) were purchased 
PAGE purified. Duplexes were obtained by heating 50 l 50 µM complementary strands 
at 85 ºC then decreasing the temperature by 0.5 ºC every 30 seconds until attaining room 
temperature. The FAM labelled 8-oxoG:A duplex used in the DNA glycosylase assay 
consisted of 5ʹ-ACA AAG AAC TTA TAG CTC CTC CTT GAG CAC ACA GAG GTG 
TTC GAT GTA GTT G/A/C GCA GGA CGG GTT CAG T/6-FAM/-3ʹ and 3ʹ-TGT TTC 
TTG AAT ATC GAG GAG GAA CTC GTG TGT CTC CAC AAG CAT GAT CAA 
C/8oxoG/G CGT CCT GCC CAA GTC A-5ʹ. The biotin labeled 8-oxoG:A duplex used 
in the binding assay consisted of 5ʹ-/BiotinTEG/AC AAA GAA CTT ATA GCT CCT 
CCT TGA GCA CAC AGA GGT GTT CAT GTA GTT G/A/C GCA GGA CGG GTT 
CAG T-3ʹ and the 8-oxoG oligomer. 
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F. DNA Glycosylase Assay 
The DNA glycosylase assay was adapted as previously reported4,6,7. The activity was 
evaluated by providing 10 nM of DNA substrate containing a single 8-oxoG:A mismatch 
to wild type or mutant MBP-MUTYH proteins (0-1000 nM) at 37ºC in a buffer (20 mM 
Tris-HCl, pH 8.0, 100 mM NaCl, 1 mM EDTA, 1 mM DTT, and 0.1 mg/mL BSA).  
Reactions were quenched after 1 hour with 80 mM NaOH followed by heating the 
samples to 90 ºC for 4 minutes, cooled and then diluted with three volumes of formamide 
spiked with GeneScan™ 500 LIZ™ Size Standard (Invitrogen). DNA fragmentation was 
determined employing capillary electrophoresis (U-M DNA Sequencing Core, ABI 3730 
DNA Analyzer). Traces were analyzed using Peak ScannerTM Software (version 1.0, 
Applied Biosystems). The percent of excised DNA was calculated as the ratio of the 6-
FAM peak area migrating at 44 oligonucleotides to the total peak area (at 44 and 66 
oligonucleotides). 
 
G. Multiple Turnover assay: Active Site Titration 
The multiple turnover assay was adapted as previously reported4,6,7.  Reactions were 
analyzed for scission of 10 nM FAM-labeled 8-oxoG duplex DNA after the addition of 
MUTYH protein. The total protein concentrations, selected to give a burst amplitude in a 
detectible range, were 25, 2670, 500 and 25 nM of MUTYH wild type, Y179C, C306W 
and G396D, respectively. Samples were drawn over a 20 minute time course and 
processed as described above. The cleaved product concentration, [P], was fitted with 
Equation 1 to determine the amplitude of the burst (A0), kB (rate constant during the burst 
phase) and kL (rate constant for the linear phase). 
Equation 1: [P] = A0[1-exp(-kBt)]+kLt  
The percent of active protein was calculated as a ratio of the A0 to total protein 
concentration. 
 
H. Binding Kinetics (Biolayer Interferometry) 
All biolayer interferometry measurements were made on an Octet RED instrument (Pall 
ForteBio, Menlo Park, CA) using streptavidin (SA) biosensors8. Assays were performed 
in 96-well black microplates at 25 ºC and 1000 rpm. All volumes were 200 μL. All 
proteins were buffer exchanged using PD-10 columns (GE Healthcare) pre-equilibrated 
with PBS then serial diluted (25, 12.5, 6.25, 3.125, 0.78125 nM) into working volumes 
with 1X Kinetics Buffer (Pall FortBio;10 mM Phosphate, pH 7.4, 150 mM NaCl, 0.02% 
Tween-20, 1 mg/mL BSA). The biotinylated duplex DNA was first immobilized onto the 
SA biosensors for 300 seconds and then equilibrated in 1X Kinetics Buffer for 300 
seconds. Protein association was performed for 150-300 seconds followed by dissociation 
into 1X Kinetics Buffer for 900 seconds. A reference sensor with immobilized dsDNA 
was subtracted from each data set. Shift data was analyzed with ForteBio’s Analysis 
software (version 7.1). Kinetic parameters kon and koff and affinity (KD) were determined 
from a global non-linear regression of association and dissociation binding kinetics using 
a 1:1 Langmuir binding model. 
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I. Fe Elemental Analysis 
The presence of elemental Fe within MUTYH protein samples was determined using a 
Thermo Scientific Element2 ICP-HRMS9. Purified proteins were dialyzed overnight to 
remove glycerol and to allow equilibration with blank buffer (20 mM Tris-HCl, pH 7.5, 
100 mM NaCl and 1 mM DTT) using a 10K MWCO Slide-A-Lyzer dialysis cassettes 
(Thermo Scientific). 
 
 
 
J. DNA Synthesis and Purification for Electrochemistry  
Thiol, FA, and OG modified DNA strands were prepared on an automated DNA 
synthesizer (Applied Biosystems) and purified by HPLC on a PLRPS column (Agilent) 
as described in previously published protocols10; unmodified strands were ordered from 
IDT and purified by HPLC. For electrochemistry, 50 μL 50 μM complementary DNA 
strands were degassed and annealed in storage buffer (5 mM sodium phosphate, pH 7.0, 
50 mM NaCl) in equimolar amounts by a 5-minute incubation at 95oC followed by slow 
cooling (1.5 hours) to RT on a thermocycler. Well-matched (WM) duplex DNA, DNA 
with an FA:OG lesion, and substrates containing an abasic site were all prepared in this 
way. Duplex sequences were as follows: 
 
WM DNA 
 
5′ – ACT GAA CCC GTC CTG GCT CAA CTA CAT GAA CAC CTC – 3′ 
3′ – TGA CTT GGG CAG GAC GCA GTT GAT GTA CTT GTG GAG – 5′ – C6 Thiol 
 
FA:OG DNA 
 
5′ – ACT GAA CCC GTC CTG GCOG CAA CTA CAT GAA CAC CTC – 3′ 
3′ – TGA CTT GGG CAG GAC GCFA GTT GAT GTA CTT GTG GAG – 5′ – C6 Thiol 
 
Abasic DNA 
 
5′ – ACT GAA CCC GTC CTG GCT CAA CTA CAT GAA CAbC CTC – 3′ 
3′ – TGA CTT GGG CAG GAC GCA GTT GAT GTA CTT GTG GAG – 5′ – C6 Thiol 
 
OG = 8-oxoguanine, FA = 2ʹ-fluoroadenine, Ab = abasic site 
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K. Electrochemistry on DNA self-assembled monolayers (SAMs) 
Electrochemical characterization of MUTYH was carried out on a multiplexed chip 
platform consisting of 16 individually-addressable gold electrodes separable into four 
quadrants10. Self-assembled DNA monolayers were formed by adding 25 μL 25 μM 
duplexed DNA in phosphate buffer (5 mM sodium phosphate, pH 7.0, 50 mM NaCl) to 
each quadrant of the chip and incubating overnight. After monolayer formation, gaps in 
the film were eliminated by backfilling for 45 minutes at RT with 1 mM 6-mercapto-1-
hexanol in phosphate buffer with 5% glycerol. The surface was then extensively rinsed in 
phosphate buffer, followed by protein storage buffer (described below). To compare 
different monolayer morphologies, DNA was incubated in phosphate buffer as described 
to generate low-density DNA monolayers (surface coverage of ~15 pmol/cm2) or in the 
presence of 100 mM MgCl2 to form high-density monolayers (surface coverage of ~40 
pmol/cm2)11,12. Bulk electrolysis experiments were performed using gold rod electrodes 
in a custom-made electrochemical cell. Experiments were carried out in air unless 
otherwise noted; anaerobic experiments were performed in a glove bag (Coy) under a 
95% N2/5% H2 atmosphere. 
MUTYH concentration was determined by UV-visible spectroscopy, using an extinction 
coefficient of 17000 M-1cm-1 at 410 nm to determine [4Fe4S] cluster concentration and 
102330 M-1cm-1 at 280 nm to determine total protein concentration. Cluster loading was 
determined by dividing [4Fe4S] cluster concentration by total protein concentration, and 
was typically around 15%. Initial characterization was carried out in Tris storage buffer 
(20 mM Tris, pH 7.4, 100 mM NaCl, 1 mM DTT, 10% glycerol v/v), while later 
electrochemical and spectroscopic experiments used a HEPES buffer (20 mM HEPES, 
pH 7.4, 100 mM KCl, 1 mM DTT, 0.5 mM EDTA, 10% glycerol v/v). MUTYH was 
transferred into HEPES using Amicon 10 kDa MW cutoff spin tubes (Millipore 
Biomedicals) at 4oC.  
Once in an appropriate buffer, MUTYH was added to a multiplexed chip and incubated 
for several hours with cyclic and square wave voltammetry (CV and SQWV, 
respectively) scans taken once per hour. In typical experiments, CV scans were taken in a 
potential window of -0.188 to 0.412 V vs NHE at a scan rate of 100 mV/s, while SQWV 
scans were taken at a frequency of 15 Hz with 0.025 V amplitude. To plot the scan rate 
dependence of CV current, scans in the same window were carried out at 20, 50, 80, 100, 
200, 500, 750, and 1000 mV/s. All experiments were performed on a CH Instruments 
potentiostat with an Ag/AgCl reference in 3 M NaCl and Pt wire counter electrode. 
Potentials were converted to NHE by adding 212 mV to the measured potentials, 
accounting for both the salt concentration (209 mV according to BASi®) and ambient 
temperature13. Bulk electrolysis was carried out at 0.412 mV versus NHE, and yields 
were estimated by subtracting the total charge passed with only buffer present from that 
passed when MUTYH was included. All buffer components were purchased from Sigma-
Aldrich, the Ag/AgCl reference electrode was purchased from BASi®, and the Pt wire 
counter electrode was purchased from the Kurt J. Lesker Company. 
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L. EPR spectroscopy 
Continuous wave X-band EPR was carried out at 10 K on a Bruker EMX instrument. 
Samples were prepared aerobically, using 150 μL 5 – 15 μM MUTYH in parallel with a 
storage buffer blank. Spectra were taken from the summation of 9 sweeps at 12.88 mW 
microwave power, 2 G modulation amplitude, and a receiver gain of 5.02 x103. 
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II. Establishment of Trans Chromosomal Configuration (Supplementary Figure 1) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure 1.  The c.918C>G MUTYH variant is situated trans relative to the 
c.1187G>A MUTYH mutation.  The c.1187G>A (p.G396D) MUTYH mutation creates a unique 
BglII restriction enzyme site which we employed to isolate the chromosomal DNA strand 
containing the c.1187G>A MUTYH mutation.  A 957 bp fragment encompassing the MUTYH 
open reading frame nucleotide positions 918 and 1187 was generated with PCR and then 
restriction enzyme digested with BglII. The digestion products were resolved on 1.5% agarose 
gel and the lower molecular weight DNA band isolated (arrow).  Sequencing of the lower 
molecular weight band demonstrated the wildtype cytosine nucleotide at position 918 consistent 
with a trans configuration of the c.1187G>A and c.918C>G MUTYH alterations. 
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III. Demonstration G:C to T:A Transversion 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure 2.  Trans c.1187G>A (p.G396D) and c.918C>G (p.C306W) MUTYH 
Mutations are Associated with the Signature G:C to T:A Transversion Distinctive of Deficient 
MUTYH DNA Repair. From one of the patient’s adenomatous polyps we extracted DNA to 
assess for the presence of the signature G:C to T:A nucleotide transversion which results from 
deficient MUTYH DNA repair.  The figure depicts a portion of the germline nucleotide sequence 
from the mutation cluster region of the APC gene (upper tracing); this sequence reveals the 
normal wildtype APC sequence.  In comparison, the lower tracing depicts the forward and 
reverse nucleotide sequence from DNA extracted from one of the patient’s colonic polyps for 
this same mutation cluster region of the APC gene; there is identified a G:C to T:A transversion 
(arrow) resulting in a premature stop codon in the APC open reading frame and pathologic APC 
protein product. 
  
Colonic Adenoma 
Normal Colonic Tissue 
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IV. Size-Exclusion, Fast Protein Liquid Chromatography of MUTYH Protein  
 
 
 
 
 
 
 
 
Supplementary Figure 3. SEC-FPLC UV260 trace of WT MUTYH following treatment with 20 
mM β-mercaptoethanol. While some soluble aggregates still occur in the void volume, the 
majority of the purified protein is monomeric. 
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V. SDS-PAGE of Purified Monomeric MUTYH Proteins (Supplementary Figure 4). 
 
 
 
 
 
 
 
Supplementary Figure 4. SDS-PAGE gel of purified monomeric MUTYH proteins. The left 
lane contains the protein molecular weight ladder. The lanes 1-4 contain 1ug of MUTYH wild 
type, Y179C, C306W, and G396D, respectively. 
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VI. Glycosylase Assay with Aggregated Protein 
 
 
 
 
 
 
Supplementary Figure 5. Glycosylase Assay Employing Aggregated MUTYH Proteins. The 
four MUTYH proteins, WT, G396D, Y179C, and C306W were overexpressed in E. coli and 
purified by nickel affinity chromatography followed by size exclusion FPLC.  All of the 
MUTYH proteins eluted as soluble aggregates in the void fraction; evidence of aggregation in 
these samples was also clear from the UV-visible spectra. Aggregated WT, G396D and Y179C 
MUTYH proteins demonstrated glycosylase activity consistent with previous reports, with 
attenuated activity observed in the G396D and Y179C MUTYH proteins4,6; aggregated C306W 
protein lacked glycosylase activity. It was suspected that aggregated protein may not exhibit 
complete native protein activity, and thus, monomeric proteins were subsequently synthesized 
and employed in subsequent experiments. 
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VII. Circular Dichroism and UV-Visible Spectra of WT MUTYH and MUTYH C306W 
 
 
 
 
 
Supplementary Figure 6. (a) Circular dichroism (CD) spectra of WT MUTYH and 
MUTYH C306W in HEPES (20 mM HEPES, pH 7.4, 100 mM KCl, 1 mM DTT, 0.5 mM 
EDTA, 10% glycerol v/v). The similarity in spectra suggest that the C306W mutation does 
not result in significant global structural perturbations. (b) UV-visible spectra of aggregated 
and monomeric WT MUTYH, and the three mutant variants, in Tris buffer (20 mM Tris-
HCl, pH 7.4, 100 mM NaCl, 1 mM DTT, 10% glycerol v/v). Aggregated spectra are clearly 
distinct from those of monomeric protein, and the absorbance at 410 nm indicates that all 
monomeric MUTYH variants effectively bound [4Fe4S] cluster.  
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VIII. Electrochemical Characterization of MUTYH in HEPES buffer 
To verify that the electrochemical properties of MUTYH were not altered in HEPES 
buffer, electrochemical analysis was performed with each variant as was done previously in Tris 
buffer (Supplementary Figure 7). In HEPES buffer, WT MUTYH underwent a slight decrease in 
midpoint potential from 105 ± 1 mV vs NHE in Tris to 93 ± 1 mV vs NHE in HEPES (Table 3), 
but the overall signal shape and properties remained unaltered. Unsurprisingly, the addition of 
more concentrated protein to the electrode (~5 μM for all electrochemical experiments in 
HEPES) gave substantially larger signals, with WT MUTYH yielding a reductive peak area of 
7.6 ± 3 nC and an oxidative peak area of -5.6 ± 3 nC on low density monolayers. Remarkably, 
although the protein was only about twice as concentrated compared with previous experiments, 
the signal was over 10 times larger, indicating that some of this increase could be attributed to 
the distinct buffer conditions.  
Like WT, all of the mutants showed ~10-fold larger signals when concentrated in 
HEPES, and their midpoint potentials decreased by a similar margin, placing all variants in the 
same potential window (Table 4). The signal from the MUTYH Y179C protein was still 
noticeably smaller than WT (reductive and oxidative peaks at 48 ± 18% and 33 ± 17% of WT), 
again most likely as a result of lower binding affinity of this mutant, while G396D was not 
significantly different from WT (reductive and oxidative peaks at 77 ± 32% and 76 ± 41% of 
WT). To ensure accurate comparison with EPR spectra, electrochemistry for the less stable 
C306W mutant was performed on the same day as EPR with the same sample stock. Consistent 
with the oxidation indicated in the UV-visible spectrum and the presence of a [3Fe4S]+ cluster in 
the EPR spectra, the reversible signal in this sample was significantly smaller than any other 
mutant (reductive and oxidative peaks 35 ± 15% and 26 ± 14% of WT) and a very prominent 
secondary reductive peak was present centered at -88 ± 6 mV vs NHE (Figure S6). The larger 
signals made this peak much more readily quantifiable compared with Tris buffer, and the total 
charge of this irreversible peak was found to represent ~20% of either peak of the reversible 
[4Fe4S]3+/2+ couple. The area in this case was lower than estimated for the C306W sample 
aerobically oxidized in Tris buffer, where the secondary peak was roughly equal in magnitude to 
the main peak, which suggested that the concentrated sample in HEPES was not 100% oxidized. 
Overall, UV-visible and EPR spectra obtained from the same MUYH C306W protein strongly 
supported the identification of the irreversible peak as a [3Fe4S]+/0 redox couple. When 
compared to WT MUTYH, or even the Y179C and G396D mutants, the susceptibility of the 
C306W [4Fe4S] cluster to degradation upon oxidation during redox signaling was apparent, and 
the irreversibility of the degradation product signal indicates that the resultant [3Fe4S]+/0 species 
does not bind DNA effectively. 
Based on the measured midpoint potentials in Tris buffer (Table 4), electrochemical 
signals from dilute MUTYH samples were most likely DNA-bound10; however, the small signal 
sizes made it impossible to determine if the signal was DNA-mediated. The substantially larger 
signals recorded in HEPES buffer with concentrated samples allowed this issue to be addressed, 
and chips containing half well-matched DNA and half DNA containing an abasic site were 
prepared for this purpose. Earlier work with DNA-mediated EndoIII signals showed a 
dependence on monolayer morphology10; thus, to see if this was also the case for MUTYH, the 
abasic site discrimination studies were carried out on both high and low density monolayers.  
On abasic DNA, a maximum CV charge attenuation of 38% for the reductive peak and 
46% for the oxidative peak was obtained on low density monolayers (Figure S7); in contrast, no 
appreciable discrimination was observed on high density monolayers. The observed abasic site 
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discrimination confirmed that MUTYH can take part in DNA-mediated signaling, and the 
differences in high and low density DNA monolayers emphasize the importance of surface 
accessibility to large proteins. The sterically hindered high density films clearly do not provide 
sufficient access to DNA in an appropriate conformation to observe such a signal, and the peaks 
seen in this case are likely attributable to DNA-bound proteins signaling directly through the 
monolayer surface10.  
Interestingly, the pattern of abasic site discrimination observed here is opposite to 
previously published data for E. coli EndoIII10; this difference can be rationalized by considering 
two important factors. First, the DNA used in the EndoIII experiments was only 15 bp, while 
EndoIII has a binding footprint of 12 bp. Thus, the protein would have taken up much of the 
available space and the cluster could readily bypass the mismatch on fully accessible low density 
DNA14.  In contrast, the DNA substrate chosen for MUTYH was 36 bp while the binding 
footprint is likely close to the 16 bp reported for mouse MUTYH15, making bypass of the abasic 
site on low density monolayers less likely. Second, a considerable size discrepancy exists 
between the two proteins: unmodified MUTYH is 61 kDa, while EndoIII is only 24 kDa. Thus, 
steric hindrance in high density films would be expected to have a greater impact on MUTYH, a 
notion supported by the observation that the largest signals obtained on high density monolayers 
containing WM DNA were ~30% smaller than the equivalent signals on low density films. 
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IX. HEPES Buffer Electrochemical Characterization 
 
 
 
 
Supplementary Figure 7. Electrochemical characterization of MUTYH variants in HEPES buffer. 
(a) Arrangement of MUTYH variants on a multiplexed chip. (b) CV (top) and SQWV (bottom) 
scans of 5 μM WT, Y179C, G396D, and C306W variants in HEPES storage buffer (20 mM 
HEPES, 100 mM KCl, 1 mM DTT, 0.5 mM EDTA, 10% glycerol v/v, pH 7.4). Under these 
conditions, substantial signals occur even by CV. The MUTYH C306W secondary peak is readily 
apparent in both CV and SQWV. CV scans were taken at a scan rate of 100 mV/s, while SQWV 
scans were taken at a frequency of 15 Hz with 0.025 V amplitude. All scans shown are an average 
obtained from at least seven separate electrodes. 
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X. Abasic Site Discrimination by WT MUTYH 
 
 
 
Supplementary Figure 8. Abasic site discrimination by WT MUTYH. 5.0 μM WT MUTYH 
was incubated in HEPES buffer (20 mM HEPES, 100 mM KCl, 1 mM DTT, 0.5 mM EDTA, 
10% glycerol v/v, pH 7.4) on a single multiplexed chip with half of the available quadrants 
containing DNA with an abasic site (light blue) near the electrode and the other half containing 
well matched (WM) DNA (dark blue). As is apparent from the SQWV voltammetry, the signal 
on WM DNA was comparable in size to previously observed signals (Figure 2), but the total 
peak area on abasic DNA was decreased by ~40%, indicating that the signal was DNA-mediated. 
The SQWV voltammograms were obtained at 15 Hz, and signal shown is the average of at least 
seven separate electrodes from two quadrants. 
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XI. Coordinating Cysteine and Neighboring Arginine Residues Predicted/Reported to 
Occur with MUTYH Associated Polyposis 
 
Supplementary Table 1: The four coordinating cysteines and surrounding arginines predicted or 
reported 16 to be associated with MAP. 
 
Residue Reported Variant  
C290 C290W17 
C297 not reported 
C300 not reported 
C306 C306W (this study) 
R241 R241W17,18 
R241G16 
R245 R245L19 
R245C16 
R245H16,20     
R247 R247G16 
R309 R309C21,22 
 
 
XII. Somatic Alterations Associated with Coordinating Cysteine and Neighboring Arginine 
Residues Predicted/Reported to Occur with Colorectal and Other Cancers 
Supplementary Table 1: The four coordinating cysteines and surrounding arginines reported 
with colorectal and other cancers from the cBioPortal database23,24. 
 
Residue Reported Somatic Variant 
Colorectal Cancer (instances) 
Reported Somatic Variant 
(other cancer, instances) 
C290 not reported not reported 
C297 not reported not reported 
C300 not reported not reported 
C306 not reported not reported 
 
R241 
 
not reported 
R241L (liver, 1) 
R241Q (unknown primary, 1) 
R245 R245C (2) R245C (lung,2) 
R247 not reported R247Q (melanoma, 1) 
R309 R309H (2) R309H (glioblastoma, 1) 
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